[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Opko Health Inc (OPK)

Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 985,153
  • Shares Outstanding, K 746,328
  • Annual Sales, $ 606,880 K
  • Annual Income, $ -225,680 K
  • EBIT $ -24 M
  • EBITDA $ 73 M
  • 60-Month Beta 1.48
  • Price/Sales 1.64
  • Price/Cash Flow N/A
  • Price/Book 0.84

Options Overview Details

View History
  • Implied Volatility 121.63% (+26.70%)
  • Historical Volatility 106.95%
  • IV Percentile 40%
  • IV Rank 10.33%
  • IV High 713.69% on 03/11/26
  • IV Low 53.43% on 08/22/25
  • Expected Move (DTE 18) 0.1615 (12.33%)
  • Put/Call Vol Ratio 0.17
  • Today's Volume 322
  • Volume Avg (30-Day) 925
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 39,588
  • Open Int (30-Day) 36,034
  • Expected Range 1.1485 to 1.4715

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.08
  • Number of Estimates 5
  • High Estimate $-0.07
  • Low Estimate $-0.08
  • Prior Year $0.03
  • Growth Rate Est. (year over year) -366.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1650 +12.45%
on 07/23/26
1.7300 -24.28%
on 07/28/26
-0.2100 (-13.82%)
since 07/02/26
3-Month
1.0750 +21.86%
on 05/15/26
1.7300 -24.28%
on 07/28/26
+0.2100 (+19.09%)
since 05/01/26
52-Week
0.9769 +34.10%
on 04/29/26
1.7300 -24.28%
on 07/28/26
+0.1200 (+10.08%)
since 08/01/25

Most Recent Stories

More News
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health

Longtime investor OPKO Health increases its position as Cocrystal advances toward norovirus Phase 1b data in late 2026 BOTHELL, Wash., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq:...

COCP : 0.9400 (+14.63%)
OPK : 1.3100 (-0.76%)
OPKO Health: Q2 Earnings Snapshot

OPKO Health: Q2 Earnings Snapshot

OPK : 1.3100 (-0.76%)
OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results

MIAMI, July 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established...

OPK : 1.3100 (-0.76%)
OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026

MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc.  (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established...

OPK : 1.3100 (-0.76%)
Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026

MIAMI, June 15, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) OPKO Biologics, an OPKO Health company, presented preclinical data for OPK8801001 at ENDO 2026, the Endocrine Society’s annual...

OPK : 1.3100 (-0.76%)
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

Multispecific antibody conjugated LNP/mRNA platform enables in vivo T-cell engineering and systemic B-cell depletion in animal models  Data will be presented at the American Society of Gene & Cell...

OPK : 1.3100 (-0.76%)
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

MIAMI, April 30, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) today announced that its subsidiary EirGen Pharma Limited (EirGen) has entered into an amendment to its agreement with...

OPK : 1.3100 (-0.76%)
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

ELMWOOD PARK, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- BioReference® Health LLC, an OPKO Health, Inc. company and a trusted provider of diagnostic testing in the United States, today announced the launch...

OPK : 1.3100 (-0.76%)
OPKO Health: Q1 Earnings Snapshot

OPKO Health: Q1 Earnings Snapshot

OPK : 1.3100 (-0.76%)
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results

MIAMI, April 28, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the...

OPK : 1.3100 (-0.76%)

Business Summary

OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and...

See More

Key Turning Points

3rd Resistance Point 1.4300
2nd Resistance Point 1.4000
1st Resistance Point 1.3550
Last Price 1.3100
1st Support Level 1.2800
2nd Support Level 1.2500
3rd Support Level 1.2050

See More

52-Week High 1.7300
Fibonacci 61.8% 1.4423
Fibonacci 50% 1.3535
Last Price 1.3100
Fibonacci 38.2% 1.2646
52-Week Low 0.9769

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.